Zai Lab Limited (NASDAQ:ZLAB) Q2 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. Thank you for standing by. And welcome to Zai Lab’s Second Quarter 2024 Financial Results Conference Call.
Zai Lab Ltd (ZLAB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,332,684 | $40,425,414 | -11% | 0.38% |
| 2. | Viking Global Andreas Halvorsen | 2,037,374 | $35,307,691 | -1% | 0.13% |
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,297,873 | $22,492,139 | +1% | 0.67% |
| 4. | Citadel Investment Group Ken Griffin | 899,666 | $15,591,211 | +37% | 0% |
| 5. | Vivo Capital Albert Cha And Frank Kung | 531,198 | $9,205,661 | 0.85% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.40 | 3,000 | 31,684 | 2024-05-13 | Filing | ||
| $20.83 | 3,000 | 23,527 | 2024-03-01 | Filing | ||
| $29.90 | 4,000 | 20,527 | 2023-12-14 | Filing | ||
| $26.93 | 5,000 | 16,527 | 2023-11-16 | Filing | ||
| $71.36 | 4,000 | Director | 4,000 | 2021-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.95 | 1,924 | 28,872 | 2024-08-19 | Filing | ||
| $16.67 | 4,352 | 43,232 | 2024-08-16 | Filing | ||
| $16.06 | 422 | 14,542 | 2024-08-15 | Filing | ||
| $16.20 | 3,115 | 20,417 | 2024-08-12 | Filing | ||
| $18.04 | 100 | 53,089 | 2024-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,336,457 | $145,845,370 | 0.02% | |
| 2. | 5,218,843 | $142,630,979 | 0.02% | |
| 3. | 4,040,282 | $110,427,843 | 0.06% | |
| 4. | 1,893,529 | $51,750,148 | 0.01% | |
| 5. | 1,490,874 | $40,745,586 | 0.1% |
News See All
Here’s Why Zai Lab Limited (ZLAB) Fell in Q1
Baron Funds, an investment management company, released its “Baron Emerging Markets Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, thank you for standing by and welcome to Zai Lab's First Quarter 2024 Financial Results Conference Call.
5 Best Emerging Markets Stocks to Buy According to Analysts
In this article, we will take a look at the 5 best emerging markets stocks to buy according to analysts.
Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
5 Most Promising Chinese Stocks According to Analysts
In this article, we discuss 5 most promising Chinese stocks according to analysts.
5 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
14 Best Short-Term Stocks to Invest In
In this article, we will take a look at 14 best short-term stocks to invest in.
Zai Lab Limited (NASDAQ:ZLAB) Q3 2023 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen-only mode.
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...
Billionaire Hedge Funds
